Tag: AWAKN Life Sciences Inc.

June 8, 2021

Awakn Life Sciences Completes Previously Announced Private Placement for Gross Proceeds of $8.3 Million

1169082 B.C. Ltd. and Awakn Life Sciences Inc. are pleased to announce the closing of the previously announced brokered private placement.
April 27, 2021

Awakn Life Sciences Initiates New Chemical Entity Development Program with Evotec as Research Partner and Addiction Expert, Prof. David Nutt, as Program Lead

DEFINING CLEAR DEVELOPMENT PATHWAY FOR NEXT GENERATION OF PSYCHEDELIC MEDICINES TO TREAT ADDICTION Awakn Life Sciences Inc. (Awakn), a biotechnology...
July 8, 2020

Professor David Nutt Joins AWAKN Life Sciences

Professor David Nutt is a world renowned neuroscientist, leading global authority on drug policy reform and former chief drug advisor...
June 18, 2020

Psychedelic Medical Start-Up AWAKN Life Sciences Enters the UK Market with Dr. Ben Sessa

Psychedelic Medical Start-Up AWAKN Life Sciences Enters the UK Market with Dr. Ben Sessa